Intercept Pharmaceuticals, Inc. et al v. Optimus Pharma Pvt. Ltd. et al
| Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd. |
| Optimus Drugs Private Ltd. and Optimus Pharma Pvt. Ltd. |
| 1:2020cv01215 |
| September 11, 2020 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 22, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 NOTICE of Appearance by R. Touhey Myer on behalf of Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd. (Attachments: #1 Certificate of Service)(Myer, R.) |
| Filing 9 WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.: For Optimus Pharma Pvt. Ltd. waiver sent on 9/18/2020, answer due 11/17/2020. (Blumenfeld, Jack) |
| Filing 8 WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.: For Optimus Drugs Private Ltd. waiver sent on 9/18/2020, answer due 11/17/2020. (Blumenfeld, Jack) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:20-cv-01214-MN, 1:20-cv-01215-MN (rjb) |
| Pro Hac Vice Attorney Mary Swears for Intercept Pharma Europe Limited and Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-UNA, 1:20-cv-01215-UNA(kmd) |
SO ORDERED re (7 in 1:20-cv-01154-MN, 7 in 1:20-cv-01215-UNA, 7 in 1:20-cv-01214-UNA, 7 in 1:20-cv-01155-MN) MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited, Intercept Pharma Europe Ltd. ORDERED by Judge Maryellen Noreika on 9/15/2020. (dlw)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (amf) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intercept Pharmaceuticals, Inc. for Intercept Pharma Europe Ltd. - filed by Intercept Pharma Europe Ltd. and Intercept Pharmaceuticals, Inc. (amf) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,337 B2; 10,174,073 B2; 7,138,390 B2. (amf) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/28/20. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 11/27/2023. (amf) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number ADEDC-3191862) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd. (Attachments: #1 Exhibits A-F, #2 Civil Cover Sheet)(amf) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
